201 related articles for article (PubMed ID: 30092333)
1. Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing.
Adams Q; Hopfensperger KM; Kim Y; Wu X; Xu W; Shukla H; McGee J; Caster JM; Flynn RT
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1543-1550. PubMed ID: 30092333
[TBL] [Abstract][Full Text] [Related]
2.
Adams Q; Hopfensperger KM; Kim Y; Wu X; Flynn RT
Med Phys; 2020 Dec; 47(12):6430-6439. PubMed ID: 33051866
[TBL] [Abstract][Full Text] [Related]
3. Interstitial rotating shield brachytherapy for prostate cancer.
Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
[TBL] [Abstract][Full Text] [Related]
4. Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.
Dadkhah H; Hopfensperger KM; Kim Y; Wu X; Flynn RT
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):719-728. PubMed ID: 28843372
[TBL] [Abstract][Full Text] [Related]
5. Paddle-based rotating-shield brachytherapy.
Liu Y; Flynn RT; Kim Y; Dadkhah H; Bhatia SK; Buatti JM; Xu W; Wu X
Med Phys; 2015 Oct; 42(10):5992-6003. PubMed ID: 26429274
[TBL] [Abstract][Full Text] [Related]
6. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison of high-dose-rate brachytherapy and intensity-modulated radiation therapy as a boost to the prostate.
Hermesse J; Biver S; Jansen N; Lenaerts E; Nickers P
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):269-76. PubMed ID: 19775833
[TBL] [Abstract][Full Text] [Related]
8. Rotating-shield brachytherapy for cervical cancer.
Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
[TBL] [Abstract][Full Text] [Related]
9. Dynamic rotating-shield brachytherapy.
Liu Y; Flynn RT; Kim Y; Yang W; Wu X
Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
[TBL] [Abstract][Full Text] [Related]
11. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
Fukuda S; Seo Y; Shiomi H; Yamada Y; Ogata T; Morimoto M; Konishi K; Yoshioka Y; Ogawa K
J Radiat Res; 2014 Nov; 55(6):1114-21. PubMed ID: 24957754
[TBL] [Abstract][Full Text] [Related]
12. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
13. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
14. A novel
Famulari G; Duclos M; Enger SA
Med Phys; 2020 Mar; 47(3):859-868. PubMed ID: 31828783
[TBL] [Abstract][Full Text] [Related]
15. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
16. A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.
Hermesse J; Biver S; Jansen N; Lenaerts E; De Patoul N; Vynckier S; Coucke P; Scalliet P; Nickers P
Strahlenther Onkol; 2009 Nov; 185(11):736-42. PubMed ID: 19899007
[TBL] [Abstract][Full Text] [Related]
17. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.
Kunogi H; Cunha JAM; Chang AJ; Gadzinski AJ; Shinohara K; Hsu IC
Brachytherapy; 2017; 16(6):1113-1118. PubMed ID: 28869143
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.
Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P
Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472
[TBL] [Abstract][Full Text] [Related]
20. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.
Hsu IC; Pickett B; Shinohara K; Krieg R; Roach M; Phillips T
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):851-8. PubMed ID: 10705005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]